News

Filter

Current filters:

Gattex

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

New treatment offers hope for short-bowel syndrome patients

19-07-2013

A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal…

Gastro-intestinalsGattexNPS PharmaceuticalsPharmaceuticalResearchteduglutide

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

17-10-2012

The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted unanimously…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulationteduglutide

FDA posts briefing papers for review of NPS Pharma's Gattex for SBS

15-10-2012

The USA Food and Drug Administration has posted briefing materials for the October 16 Gastrointestinal…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulation

NPS Pharma posts overall positive Gattex data, but shares plunge due to two deaths

01-11-2011

Shares in USA-based NPS Pharmaceuticals (Nasdaq: NPSP) plummeted as much as 38% to $4.92 in morning trading…

Gastro-intestinalsGattexNPS PharmaceuticalsNycomedPharmaceuticalResearchRevestive

NPS Pharma soars as Gattex meets primary efficacy endpoint in Ph III study

01-02-2011

Shares of US specialty drug developer NPS Pharmaceuticals (Nasdaq: NPSP) soared 22% to $9.30 in early…

Gastro-intestinalsGattexNPS PharmaceuticalsNycomedPharmaceuticalResearchteduglutide

Back to top